Moderna COVID-19 vaccine shows 94% efficacy, eligible for approval: panel
Social affairsMay 10, 2021
A South Korean panel of experts said Monday that the vaccine for the novel coronavirus by US pharmaceutical company Moderna Inc. showed more than a 94 percent efficacy rate and is eligible for use. The advisory board consisting of outside experts announced its review on the efficacy and safety of the Moderna vaccine, according to the Ministry of Food and Drug Safety. The panel's review is the first step of three separate independent evaluations before the ministry gives final approval. The p